【24h】

Epigenetic variants and biomarkers for colon cancer

机译:Epigenetic variants and biomarkers for colon cancer

获取原文
获取原文并翻译 | 示例
       

摘要

Colorectal cancer (CRC), the second most common tumor type in the US, is the third leading cause of cancer-related mortality, accounting for nearly 9 percent of ail cancer-related deaths. Accumulation of mutations in multiple critical genes is believed to cause the transformation of a normal mucosal epithelial cell into a cancer cell, Mutations in critical genes, such as APC, KRAS, TP53, MMR family genes, CTNNB1, and SMAD4, have been implicated in colon tumorigenesis. In addition to genetic mutations, epigenetic alterations also play important roles in cancer initiation and development. One subtype of CRC, the CpG island methylator phenotype (CIMP), is characterized by hypermethylation of the CpG islands in the promoter regions of many tumor suppressor and DNA repair genes, resulting in gene inactivation. Other epigenetic alterations in CRC include DNA methylation, his-tone modification, microRNA action, microsatellite instability, and chromosomal instability.

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号